Skip to content
‹ Back to IndustriesSciences

Addressing the Lack of Diversity in STEM Careers

Minorities continue to face challenges in pursuing STEM careers due to a lack of access to resources and institutional biases. Early education programs often fail to expose them to technology career paths or inspire a love for technology. The lack of role models within their circles discourages them from pursuing STEM careers and has…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Diversity in StemEducationInstitutional BiasesMentorship
Share

Key takeaways

01

Minorities continue to face challenges in pursuing STEM careers due to a lack of access to resources and institutional biases.

02

Early education programs often fail to expose them to technology career paths or inspire a love for technology.

03

The lack of role models within their circles discourages them from pursuing STEM careers and has…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.

Start free

Minorities continue to face challenges in pursuing STEM careers due to a lack of access to resources and institutional biases. Early education programs often fail to expose them to technology career paths or inspire a love for technology. The lack of role models within their circles discourages them from pursuing STEM careers and has created a pressing need for addressing educational disparities in STEM for underserved youth.

Programs like Challenges and Opportunities for Minorities in STEM Jobs and All-In STEM, founded by Dr. Kenneth Gibbs Jr. and Dr. Ciara Sivels exist with the purpose of addressing educational disparities in STEM for Underserved Youth. The program offers hands-on experience and technical knowledge to students, as well as the opportunity to work in a STEM field of their interest. Olwyn DePutron, the Director of Step IT Up America at UST, another similar program, shares their opinion about providing a path for underrepresented minorities to enter and thrive in STEM careers, where a more diverse and inclusive future for the industry can be created.

Olwyn’s Thoughts:

“In today’s workplace, there’s still a limited number of minorities pursuing STEM careers. The reasons behind this falls into a few buckets. One reason is that in the early education age, there are not a lot of programs available within the schools minorities attend to expose them to the different technology career paths or even to help them to build a love for things technology-wise in addition to the early education.

The familiar circles or relationship circles that minorities grow up in and the individuals they encounter often have jobs outside of technology. There’s often not a role model who would encourage them to pursue STEM careers or to pursue them to build skill sets for STEM careers.

Lastly, the opportunities afforded to them are often done so without the education, without the mentorship, and without guidance. They would not be directed to STEM fields or STEM careers. The Step Up program gives them the education, it gives them the mentorship, and it also gives them an opportunity, an open door to start off that career in technology.

The program allows them to pursue a passion that they may have for technology and train them up in a skillset. From the beginning, all the way to giving them hands-on experience, technical knowledge, and an opportunity to work in a field or in a specific role where they can enhance and build upon the skillset that they learned in the classroom.

In addition, they’re mentored not only by a coach but also a mentor who is within the client organization. Lastly, the client in partnership with us affords them an opportunity to get a role within that organization and continue to build up on their skillset and continue to move forward in a technology field of their interest.”

Article by Galina Mikova.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0. No credit card. Company confirmation required.

More Sciences Insights

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

Contract Pharma reports bioTRAK data projecting CDMOs will install roughly 120 bioreactors by 2030. It says 71% of added volume is large-scale stainless steel, while 61% of systems are single-use.

  • 01Utilization discipline is still driving builds: BioTRAK’s Dawn Ecker told Contract Pharma expansion conversations typically start after a site is booked above ~80% for several years.

Sep 22, 2026

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512